Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas

NCT00083122 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00083122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00083122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
May 31, 2012
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent ovarian epithelial cancer, recurrent primary peritoneal cavity cancer, stage iiia ovarian epithelial cancer, stage iiia primary peritoneal cavity cancer, stage iiib ovarian epithelial cancer, stage iiib primary peritoneal cavity cancer, stage iiic ovarian epithelial cancer, stage iiic primary peritoneal cavity cancer, stage iv ovarian epithelial cancer, stage iv primary peritoneal cavity cancer